Site Therapeutics is using high-throughput functional genomics to create fine-tuned control of immune cell function to treat a variety of immune-related conditions. Site Therapeutics is backed by The Column Group and is currently in stealth mode, so they have not publicly disclosed their research yet.

Site Therapeutics

I'm excited to be officially joining the Site Therapeutics team as SVP of Data Science. This is my ideal move from the deeply satisfying experience I had at Maze Therapeutics, which is now moving multiple assets into the clinic.

Like Maze, Site strives to understand variant function in the context of human health and disease and related cellular phenotypes. We are focusing on variation that drives immune cell function by building a high-throughput genomics platform based on work done in the Marson Lab at UCSF/Gladstone.

In addition to the application of innovative new lab technologies, we will be developing a novel computational platform to accelerate target discovery and validation, thereby increasing the probability of success in our drug discovery programs.

I am thrilled to be joining colleagues old and new in this next adventure.

We're hiring! Site Therapeutics is using novel technologies in functional genomics and protein modeling to revolutionize drug discovery. Join the team as its inaugural Computational Biologist and be part of building this exciting new company. #hiring #computationalbiology #drugdiscovery 

Site Therapeutics

About: